High throughput generation and affinity maturation of humanized antibody
Abstract
Compositions, methods, and kits are provided for efficiently generating and screening humanized antibody with high affinity against a specific antigen. The library of humanized antibody is generated by mutagenizing a chimeric antibody template that combines human antibody framework and antigen binding sites of a non-human antibody. Alternatively, the library of humanized antibody is generated by grafting essential antigen-recognition segment(s) such as CDRs of the non-human antibody into the corresponding position(s) of each member of a human antibody library. This library of humanized antibody is then screened for high affinity binding toward a specific antigen in vivo in organism such as yeast or in vitro using techniques such as ribosome display or mRNA display. The overall process can be efficiently performed in a high throughput and automated manner, thus mimicking the natural process of antibody affinity maturation.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for screening a library of humanized antibody in yeast, comprising:
expressing a library of humanized antibodies in yeast cells; expressing a specific target protein in the yeast cells expressing the humanized antibodies; and selecting those yeast cells in which a reporter gene is expressed, the expression of the reporter gene being activated by binding of the humanized antibody to the target protein.
2 . The method of claim 1 , wherein a member of the library of humanized antibody contains one or more CDRs of a non-human antibody grafted into a human antibody framework.
3 . The method of claim 1 , wherein the library of humanized antibody are generated by mutagenizing a chimeric antibody that contains one or more CDRs of a non-human antibody grafted into a human antibody framework.
4 . A method for screening a library of humanized antibody in vitro, comprising:
expressing a library of humanized antibodies in vitro; displaying the library of humanized antibodies on ribosome; contacting the ribosome displaying the library of humanized antibodies with a target antigen; and selecting those ribosomes that bind to the target antigen,
5 . The method of claim 4 , wherein the target antigen is immobilized to a substrate.
6 . The method of claim 4 , wherein the target antigen is fluorescence labeled.
7 . A method for screening a library of humanized antibody in vitro, comprising:
transcribing a library of cDNA encoding a library of humanized antibodies in vitro to produce a library of mRNA; contacting the library of mRNA with a peptidyl acceptor linker to produce a library of modified mRNA; translating the library of modified mRNA in vitro to produce a library of humanized antibody, wherein the translated humanized antibody is covalently linked to the modified mRNA by the peptidyl acceptor linker; and contacting the library of humanized antibodies linked with the modified mRNA with a target antigen; and selecting the humanized antibody that bind to the target antigen,
8 . The method of claim 7 , wherein the peptidyl acceptor linker is puromycin.Join the waitlist — get patent alerts
Track US2004067532A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.